Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant

190
41
Favorite

Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant

CNBC2021-07-09

KEY POINTS Pfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant. Clinical studies could begin as early as August, subject to ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

190

Report

Comment（41）

Jackytan
·2021-07-09
Eventually develop mRNA flu vaccine, then include COVID-19 booster inside. That's what we're waiting for.
Reply
Like
Report
CharWF
·2021-07-09
Oh good news.
Reply
1
Report
CWL711
·2021-07-09
Good ! Like please thank you
Reply
2
Report
Degenerated
·2021-07-09
Expected this to come.
Reply
Like
Report
Khoo12
·2021-07-09
Oo
Reply
Like
Report
woonws
·2021-07-09
Hopefully not just Delta but also other variants of concern... but it is like influenza with annual shots countering different variants
Reply
4
Report
Wallstrtbets
·2021-07-09
More profits.
Reply
5
Report
Grest
·2021-07-09
Uptrend!
Reply
2
Report
Ignis
·2021-07-09
Better be better
Reply
3
Report
BurningSun
·2021-07-09
From Alpha to Delta to ??? variant…. Can only hope for the best outcome for this pandamic
Reply
3
Report
EHG
·2021-07-09
Like
Reply
4
Report
Fold Replies
- Ignis:
  hi
  2021-07-09
  Reply
  Report
Chrnox
·2021-07-09
Like pls. Thank you
Reply
3
Report
fidllama
·2021-07-09
okay wow
Reply
2
Report
Mr. T
·2021-07-09
Please like
Reply
6
Report
Yuanecute
·2021-07-09
pls like n comment
Reply
7
Report
Fold Replies
- Yuanecute:
  thanks
  2021-07-12
  Reply
  Report
- Yuanecute:
  thanks
  2021-07-10
  Reply
  Report
- Foxie:
  Good
  2021-07-09
  Reply
  Report
View more 1 comments
Sharon87
·2021-07-09
Thats good to hear!
Reply
2
Report
TK360
·2021-07-09
Great
Reply
3
Report
BeautyTrade
·2021-07-09
Non stop vaccine
Reply
6
Report
Fold Replies
- Julisuqin:
  Indeed, need to be mentally prepared every year now
  2021-07-09
  Reply
  Report
Lamborghini1
·2021-07-09
Yes
Reply
3
Report
cyak
·2021-07-09
That fast?
Reply
4
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1141664359?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-07-09 07:25","share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","id":"1141664359","market":"hk","top_or_hot":-1,"title":"Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant","media":"CNBC","content":"<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Source Link</a>\n\n</div>\n","source":"cnbc_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer says it is developing a Covid booster shot to target the highly transmissible delta variant\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-09 07:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PFE","symbol_name":"辉瑞","start_time":0,"source_url":"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html","article_id":"1141664359","we_media_id":null,"thumbnails":[],"rights":{"source":"cnbc_highlight","url":"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.ArticleHeader-headline{#titleStyle#}a{#lv2TextColor#}.ArticleHeader-time, .Author-authorNameAndSocial a{#sourceStyle#;}","selectors":".PageBuilder-pageWrapper","filters":".ArticleHeader-eyebrow, .RelatedTags-relatedTags","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=1141664359","pubTimestamp":1625786702,"sourceInfo":{"source_id":"cnbc_highlight","name":"CNBC"},"weMediaInfo":null,"summary":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot inten","collect":0,"end_time":0,"defaultTopTitle":"cnbc.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"PFE":"辉瑞"},"translate_title":"辉瑞表示，它正在开发一种针对高度传播的三角洲变体的Covid增强注射","themeId":null,"isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/69aa4dbf8b9b8f78b9a0e59234e22387","symbols_score_info":{"PFE":0.9},"content_text":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to regulatory approvals.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated.\n\nPfizerandBioNTechannounced Thursday they are developing a Covid-19 booster shot intended to target the delta variant as concerns rise about the highly transmissible strain that is already the dominant form of the disease in the United States.\nThe companies said although they believe a third shot of their current two-dose vaccine has the potential to preserve the \"highest levels\" of protection against all currently known variants, including delta, they are \"remaining vigilant\" and developing an updated version of the vaccine.\n“As seen in real world evidence released from the Israel Ministry of Health, vaccine efficacy has declined six months post-vaccination, at the same time that the Delta variant is becoming the dominate variant in the country,” the companies said in a written statement.\n“These findings are consistent with an ongoing analysis from the companies’ Phase 3 study,” they said. “That is why we have said, and we continue to believe that it is likely, based on the totality of the data we have to date, that a third dose may be needed within 6 to 12 months after full vaccination.”\nClinical studies could begin as early as August, subject to regulatory approvals, the companies said.\nThe announcement comes the same day Olympics organizers saidthey are banning all spectatorsfrom the games this year after Japan declared a state of emergency that’s meant to curb a wave of new Covid-19 infections due in part to the delta variant.\nDelta is estimated by the World Health Organization to be about 55% more transmissible than alpha, the variant first found in the United Kingdom that once dominated the U.S. While current evidence shows Pfizer’s is highly effective against delta in preventing severe disease and death, it may not protect as well against mild disease and spreading the disease to others, scientists say.\nOn Monday, Israeli officialsreporteda decrease in the effectiveness of the Pfizer-BioNTech vaccine in preventing infections and symptomatic illness but said it remained highly effective in preventing serious illness.\nIn the U.S, health officials are urging all eligible Americans to get vaccinated as quickly as possible, especially before the fall season when delta isexpected to cause another surge in new coronavirus cases, particularly in places with the lowest vaccination rates.\nThere are about 1,000 counties in the U.S. that have Covid vaccination coverage of less than 30%, mostly located in the Southeast and Midwest, CDC Director Dr. Rochelle Walensky recently said. The agency is already seeing increasing rates of infection in those areas due to the further spread of the delta variant.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated because they expect vaccine-induced immunity to wane over time. They also said it’s likely people will need to get additional shots each year.\nPfizer and BioNTech are developing booster shots and are expected to shortly seek U.S. authorization for a third dose of its vaccine.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":143476601,"gmtCreate":1625813889703,"gmtModify":1703749086191,"author":{"id":"3555065151273039","authorId":"3555065151273039","name":"Jackytan","avatar":"https://community-static.tradeup.com/news/6b0314202f797581d3e8716a67f721e6","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":6,"crmLevelSwitch":1},"htmlText":"Eventually develop mRNA flu vaccine, then include COVID-19 booster inside. That's what we're waiting for.&nbsp;","listText":"Eventually develop mRNA flu vaccine, then include COVID-19 booster inside. That's what we're waiting for.&nbsp;","text":"Eventually develop mRNA flu vaccine, then include COVID-19 booster inside. That's what we're waiting for.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/143476601","repostId":1141664359,"repostType":4,"repost":{"id":"1141664359","pubTimestamp":1625786702,"share":"https://www.laohu8.com/m/news/1141664359?lang=&edition=full","pubTime":"2021-07-09 07:25","market":"us","language":"en","title":"Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant","url":"https://stock-news.laohu8.com/highlight/detail?id=1141664359","media":"CNBC","summary":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot inten","content":"<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer says it is developing a Covid booster shot to target the highly transmissible delta variant\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-09 07:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1141664359","content_text":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to regulatory approvals.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated.\n\nPfizerandBioNTechannounced Thursday they are developing a Covid-19 booster shot intended to target the delta variant as concerns rise about the highly transmissible strain that is already the dominant form of the disease in the United States.\nThe companies said although they believe a third shot of their current two-dose vaccine has the potential to preserve the \"highest levels\" of protection against all currently known variants, including delta, they are \"remaining vigilant\" and developing an updated version of the vaccine.\n“As seen in real world evidence released from the Israel Ministry of Health, vaccine efficacy has declined six months post-vaccination, at the same time that the Delta variant is becoming the dominate variant in the country,” the companies said in a written statement.\n“These findings are consistent with an ongoing analysis from the companies’ Phase 3 study,” they said. “That is why we have said, and we continue to believe that it is likely, based on the totality of the data we have to date, that a third dose may be needed within 6 to 12 months after full vaccination.”\nClinical studies could begin as early as August, subject to regulatory approvals, the companies said.\nThe announcement comes the same day Olympics organizers saidthey are banning all spectatorsfrom the games this year after Japan declared a state of emergency that’s meant to curb a wave of new Covid-19 infections due in part to the delta variant.\nDelta is estimated by the World Health Organization to be about 55% more transmissible than alpha, the variant first found in the United Kingdom that once dominated the U.S. While current evidence shows Pfizer’s is highly effective against delta in preventing severe disease and death, it may not protect as well against mild disease and spreading the disease to others, scientists say.\nOn Monday, Israeli officialsreporteda decrease in the effectiveness of the Pfizer-BioNTech vaccine in preventing infections and symptomatic illness but said it remained highly effective in preventing serious illness.\nIn the U.S, health officials are urging all eligible Americans to get vaccinated as quickly as possible, especially before the fall season when delta isexpected to cause another surge in new coronavirus cases, particularly in places with the lowest vaccination rates.\nThere are about 1,000 counties in the U.S. that have Covid vaccination coverage of less than 30%, mostly located in the Southeast and Midwest, CDC Director Dr. Rochelle Walensky recently said. The agency is already seeing increasing rates of infection in those areas due to the further spread of the delta variant.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated because they expect vaccine-induced immunity to wane over time. They also said it’s likely people will need to get additional shots each year.\nPfizer and BioNTech are developing booster shots and are expected to shortly seek U.S. authorization for a third dose of its vaccine.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":143445350,"gmtCreate":1625813174170,"gmtModify":1703749074902,"author":{"id":"3582633338719689","authorId":"3582633338719689","name":"CharWF","avatar":"https://static.tigerbbs.com/480b91cd8f3c49bc36c742b17b0ae054","vip":1,"hat":"https://static.tigerbbs.com/4c5ceab71416b120bab4604c0754b52a","crmLevel":2,"crmLevelSwitch":0},"htmlText":"Oh good news.&nbsp;","listText":"Oh good news.&nbsp;","text":"Oh good news.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/143445350","repostId":1141664359,"repostType":4,"repost":{"id":"1141664359","pubTimestamp":1625786702,"share":"https://www.laohu8.com/m/news/1141664359?lang=&edition=full","pubTime":"2021-07-09 07:25","market":"us","language":"en","title":"Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant","url":"https://stock-news.laohu8.com/highlight/detail?id=1141664359","media":"CNBC","summary":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot inten","content":"<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer says it is developing a Covid booster shot to target the highly transmissible delta variant\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-09 07:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1141664359","content_text":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to regulatory approvals.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated.\n\nPfizerandBioNTechannounced Thursday they are developing a Covid-19 booster shot intended to target the delta variant as concerns rise about the highly transmissible strain that is already the dominant form of the disease in the United States.\nThe companies said although they believe a third shot of their current two-dose vaccine has the potential to preserve the \"highest levels\" of protection against all currently known variants, including delta, they are \"remaining vigilant\" and developing an updated version of the vaccine.\n“As seen in real world evidence released from the Israel Ministry of Health, vaccine efficacy has declined six months post-vaccination, at the same time that the Delta variant is becoming the dominate variant in the country,” the companies said in a written statement.\n“These findings are consistent with an ongoing analysis from the companies’ Phase 3 study,” they said. “That is why we have said, and we continue to believe that it is likely, based on the totality of the data we have to date, that a third dose may be needed within 6 to 12 months after full vaccination.”\nClinical studies could begin as early as August, subject to regulatory approvals, the companies said.\nThe announcement comes the same day Olympics organizers saidthey are banning all spectatorsfrom the games this year after Japan declared a state of emergency that’s meant to curb a wave of new Covid-19 infections due in part to the delta variant.\nDelta is estimated by the World Health Organization to be about 55% more transmissible than alpha, the variant first found in the United Kingdom that once dominated the U.S. While current evidence shows Pfizer’s is highly effective against delta in preventing severe disease and death, it may not protect as well against mild disease and spreading the disease to others, scientists say.\nOn Monday, Israeli officialsreporteda decrease in the effectiveness of the Pfizer-BioNTech vaccine in preventing infections and symptomatic illness but said it remained highly effective in preventing serious illness.\nIn the U.S, health officials are urging all eligible Americans to get vaccinated as quickly as possible, especially before the fall season when delta isexpected to cause another surge in new coronavirus cases, particularly in places with the lowest vaccination rates.\nThere are about 1,000 counties in the U.S. that have Covid vaccination coverage of less than 30%, mostly located in the Southeast and Midwest, CDC Director Dr. Rochelle Walensky recently said. The agency is already seeing increasing rates of infection in those areas due to the further spread of the delta variant.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated because they expect vaccine-induced immunity to wane over time. They also said it’s likely people will need to get additional shots each year.\nPfizer and BioNTech are developing booster shots and are expected to shortly seek U.S. authorization for a third dose of its vaccine.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":143424941,"gmtCreate":1625811428183,"gmtModify":1703749044663,"author":{"id":"3579262958727025","authorId":"3579262958727025","name":"CWL711","avatar":"https://static.tigerbbs.com/982058e5cb33e9069dbb2ca28d3fc46e","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"Good ! Like please thank you","listText":"Good ! Like please thank you","text":"Good ! Like please thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/143424941","repostId":1141664359,"repostType":4,"repost":{"id":"1141664359","pubTimestamp":1625786702,"share":"https://www.laohu8.com/m/news/1141664359?lang=&edition=full","pubTime":"2021-07-09 07:25","market":"us","language":"en","title":"Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant","url":"https://stock-news.laohu8.com/highlight/detail?id=1141664359","media":"CNBC","summary":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot inten","content":"<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer says it is developing a Covid booster shot to target the highly transmissible delta variant\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-09 07:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1141664359","content_text":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to regulatory approvals.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated.\n\nPfizerandBioNTechannounced Thursday they are developing a Covid-19 booster shot intended to target the delta variant as concerns rise about the highly transmissible strain that is already the dominant form of the disease in the United States.\nThe companies said although they believe a third shot of their current two-dose vaccine has the potential to preserve the \"highest levels\" of protection against all currently known variants, including delta, they are \"remaining vigilant\" and developing an updated version of the vaccine.\n“As seen in real world evidence released from the Israel Ministry of Health, vaccine efficacy has declined six months post-vaccination, at the same time that the Delta variant is becoming the dominate variant in the country,” the companies said in a written statement.\n“These findings are consistent with an ongoing analysis from the companies’ Phase 3 study,” they said. “That is why we have said, and we continue to believe that it is likely, based on the totality of the data we have to date, that a third dose may be needed within 6 to 12 months after full vaccination.”\nClinical studies could begin as early as August, subject to regulatory approvals, the companies said.\nThe announcement comes the same day Olympics organizers saidthey are banning all spectatorsfrom the games this year after Japan declared a state of emergency that’s meant to curb a wave of new Covid-19 infections due in part to the delta variant.\nDelta is estimated by the World Health Organization to be about 55% more transmissible than alpha, the variant first found in the United Kingdom that once dominated the U.S. While current evidence shows Pfizer’s is highly effective against delta in preventing severe disease and death, it may not protect as well against mild disease and spreading the disease to others, scientists say.\nOn Monday, Israeli officialsreporteda decrease in the effectiveness of the Pfizer-BioNTech vaccine in preventing infections and symptomatic illness but said it remained highly effective in preventing serious illness.\nIn the U.S, health officials are urging all eligible Americans to get vaccinated as quickly as possible, especially before the fall season when delta isexpected to cause another surge in new coronavirus cases, particularly in places with the lowest vaccination rates.\nThere are about 1,000 counties in the U.S. that have Covid vaccination coverage of less than 30%, mostly located in the Southeast and Midwest, CDC Director Dr. Rochelle Walensky recently said. The agency is already seeing increasing rates of infection in those areas due to the further spread of the delta variant.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated because they expect vaccine-induced immunity to wane over time. They also said it’s likely people will need to get additional shots each year.\nPfizer and BioNTech are developing booster shots and are expected to shortly seek U.S. authorization for a third dose of its vaccine.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":143439530,"gmtCreate":1625807554020,"gmtModify":1703748977765,"author":{"id":"3582457483215828","authorId":"3582457483215828","name":"Degenerated","avatar":"https://static.tigerbbs.com/fcad9a3e2865b545e3a1f4ec2cc9917a","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Expected this to come.&nbsp;","listText":"Expected this to come.&nbsp;","text":"Expected this to come.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/143439530","repostId":1141664359,"repostType":4,"repost":{"id":"1141664359","pubTimestamp":1625786702,"share":"https://www.laohu8.com/m/news/1141664359?lang=&edition=full","pubTime":"2021-07-09 07:25","market":"us","language":"en","title":"Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant","url":"https://stock-news.laohu8.com/highlight/detail?id=1141664359","media":"CNBC","summary":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot inten","content":"<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer says it is developing a Covid booster shot to target the highly transmissible delta variant\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-09 07:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1141664359","content_text":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to regulatory approvals.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated.\n\nPfizerandBioNTechannounced Thursday they are developing a Covid-19 booster shot intended to target the delta variant as concerns rise about the highly transmissible strain that is already the dominant form of the disease in the United States.\nThe companies said although they believe a third shot of their current two-dose vaccine has the potential to preserve the \"highest levels\" of protection against all currently known variants, including delta, they are \"remaining vigilant\" and developing an updated version of the vaccine.\n“As seen in real world evidence released from the Israel Ministry of Health, vaccine efficacy has declined six months post-vaccination, at the same time that the Delta variant is becoming the dominate variant in the country,” the companies said in a written statement.\n“These findings are consistent with an ongoing analysis from the companies’ Phase 3 study,” they said. “That is why we have said, and we continue to believe that it is likely, based on the totality of the data we have to date, that a third dose may be needed within 6 to 12 months after full vaccination.”\nClinical studies could begin as early as August, subject to regulatory approvals, the companies said.\nThe announcement comes the same day Olympics organizers saidthey are banning all spectatorsfrom the games this year after Japan declared a state of emergency that’s meant to curb a wave of new Covid-19 infections due in part to the delta variant.\nDelta is estimated by the World Health Organization to be about 55% more transmissible than alpha, the variant first found in the United Kingdom that once dominated the U.S. While current evidence shows Pfizer’s is highly effective against delta in preventing severe disease and death, it may not protect as well against mild disease and spreading the disease to others, scientists say.\nOn Monday, Israeli officialsreporteda decrease in the effectiveness of the Pfizer-BioNTech vaccine in preventing infections and symptomatic illness but said it remained highly effective in preventing serious illness.\nIn the U.S, health officials are urging all eligible Americans to get vaccinated as quickly as possible, especially before the fall season when delta isexpected to cause another surge in new coronavirus cases, particularly in places with the lowest vaccination rates.\nThere are about 1,000 counties in the U.S. that have Covid vaccination coverage of less than 30%, mostly located in the Southeast and Midwest, CDC Director Dr. Rochelle Walensky recently said. The agency is already seeing increasing rates of infection in those areas due to the further spread of the delta variant.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated because they expect vaccine-induced immunity to wane over time. They also said it’s likely people will need to get additional shots each year.\nPfizer and BioNTech are developing booster shots and are expected to shortly seek U.S. authorization for a third dose of its vaccine.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":143543079,"gmtCreate":1625804521691,"gmtModify":1703748916691,"author":{"id":"3564738902623228","authorId":"3564738902623228","name":"Khoo12","avatar":"https://static.tigerbbs.com/a1637796379aeed1538616117eb09330","vip":1,"crmLevel":6,"crmLevelSwitch":0},"htmlText":"Oo","listText":"Oo","text":"Oo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/143543079","repostId":1141664359,"repostType":4,"repost":{"id":"1141664359","pubTimestamp":1625786702,"share":"https://www.laohu8.com/m/news/1141664359?lang=&edition=full","pubTime":"2021-07-09 07:25","market":"us","language":"en","title":"Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant","url":"https://stock-news.laohu8.com/highlight/detail?id=1141664359","media":"CNBC","summary":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot inten","content":"<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer says it is developing a Covid booster shot to target the highly transmissible delta variant\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-09 07:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1141664359","content_text":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to regulatory approvals.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated.\n\nPfizerandBioNTechannounced Thursday they are developing a Covid-19 booster shot intended to target the delta variant as concerns rise about the highly transmissible strain that is already the dominant form of the disease in the United States.\nThe companies said although they believe a third shot of their current two-dose vaccine has the potential to preserve the \"highest levels\" of protection against all currently known variants, including delta, they are \"remaining vigilant\" and developing an updated version of the vaccine.\n“As seen in real world evidence released from the Israel Ministry of Health, vaccine efficacy has declined six months post-vaccination, at the same time that the Delta variant is becoming the dominate variant in the country,” the companies said in a written statement.\n“These findings are consistent with an ongoing analysis from the companies’ Phase 3 study,” they said. “That is why we have said, and we continue to believe that it is likely, based on the totality of the data we have to date, that a third dose may be needed within 6 to 12 months after full vaccination.”\nClinical studies could begin as early as August, subject to regulatory approvals, the companies said.\nThe announcement comes the same day Olympics organizers saidthey are banning all spectatorsfrom the games this year after Japan declared a state of emergency that’s meant to curb a wave of new Covid-19 infections due in part to the delta variant.\nDelta is estimated by the World Health Organization to be about 55% more transmissible than alpha, the variant first found in the United Kingdom that once dominated the U.S. While current evidence shows Pfizer’s is highly effective against delta in preventing severe disease and death, it may not protect as well against mild disease and spreading the disease to others, scientists say.\nOn Monday, Israeli officialsreporteda decrease in the effectiveness of the Pfizer-BioNTech vaccine in preventing infections and symptomatic illness but said it remained highly effective in preventing serious illness.\nIn the U.S, health officials are urging all eligible Americans to get vaccinated as quickly as possible, especially before the fall season when delta isexpected to cause another surge in new coronavirus cases, particularly in places with the lowest vaccination rates.\nThere are about 1,000 counties in the U.S. that have Covid vaccination coverage of less than 30%, mostly located in the Southeast and Midwest, CDC Director Dr. Rochelle Walensky recently said. The agency is already seeing increasing rates of infection in those areas due to the further spread of the delta variant.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated because they expect vaccine-induced immunity to wane over time. They also said it’s likely people will need to get additional shots each year.\nPfizer and BioNTech are developing booster shots and are expected to shortly seek U.S. authorization for a third dose of its vaccine.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":143588277,"gmtCreate":1625801908299,"gmtModify":1703748861480,"author":{"id":"3581999478634265","authorId":"3581999478634265","name":"woonws","avatar":"https://static.tigerbbs.com/f26ed1a10ee84ab97229aad191ef3133","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Hopefully not just Delta but also other variants of concern... but it is like influenza with annual shots countering different variants","listText":"Hopefully not just Delta but also other variants of concern... but it is like influenza with annual shots countering different variants","text":"Hopefully not just Delta but also other variants of concern... but it is like influenza with annual shots countering different variants","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/143588277","repostId":1141664359,"repostType":4,"repost":{"id":"1141664359","pubTimestamp":1625786702,"share":"https://www.laohu8.com/m/news/1141664359?lang=&edition=full","pubTime":"2021-07-09 07:25","market":"us","language":"en","title":"Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant","url":"https://stock-news.laohu8.com/highlight/detail?id=1141664359","media":"CNBC","summary":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot inten","content":"<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer says it is developing a Covid booster shot to target the highly transmissible delta variant\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-09 07:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1141664359","content_text":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to regulatory approvals.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated.\n\nPfizerandBioNTechannounced Thursday they are developing a Covid-19 booster shot intended to target the delta variant as concerns rise about the highly transmissible strain that is already the dominant form of the disease in the United States.\nThe companies said although they believe a third shot of their current two-dose vaccine has the potential to preserve the \"highest levels\" of protection against all currently known variants, including delta, they are \"remaining vigilant\" and developing an updated version of the vaccine.\n“As seen in real world evidence released from the Israel Ministry of Health, vaccine efficacy has declined six months post-vaccination, at the same time that the Delta variant is becoming the dominate variant in the country,” the companies said in a written statement.\n“These findings are consistent with an ongoing analysis from the companies’ Phase 3 study,” they said. “That is why we have said, and we continue to believe that it is likely, based on the totality of the data we have to date, that a third dose may be needed within 6 to 12 months after full vaccination.”\nClinical studies could begin as early as August, subject to regulatory approvals, the companies said.\nThe announcement comes the same day Olympics organizers saidthey are banning all spectatorsfrom the games this year after Japan declared a state of emergency that’s meant to curb a wave of new Covid-19 infections due in part to the delta variant.\nDelta is estimated by the World Health Organization to be about 55% more transmissible than alpha, the variant first found in the United Kingdom that once dominated the U.S. While current evidence shows Pfizer’s is highly effective against delta in preventing severe disease and death, it may not protect as well against mild disease and spreading the disease to others, scientists say.\nOn Monday, Israeli officialsreporteda decrease in the effectiveness of the Pfizer-BioNTech vaccine in preventing infections and symptomatic illness but said it remained highly effective in preventing serious illness.\nIn the U.S, health officials are urging all eligible Americans to get vaccinated as quickly as possible, especially before the fall season when delta isexpected to cause another surge in new coronavirus cases, particularly in places with the lowest vaccination rates.\nThere are about 1,000 counties in the U.S. that have Covid vaccination coverage of less than 30%, mostly located in the Southeast and Midwest, CDC Director Dr. Rochelle Walensky recently said. The agency is already seeing increasing rates of infection in those areas due to the further spread of the delta variant.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated because they expect vaccine-induced immunity to wane over time. They also said it’s likely people will need to get additional shots each year.\nPfizer and BioNTech are developing booster shots and are expected to shortly seek U.S. authorization for a third dose of its vaccine.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":143518844,"gmtCreate":1625801115588,"gmtModify":1703748846861,"author":{"id":"3566244878628904","authorId":"3566244878628904","name":"Wallstrtbets","avatar":"https://static.tigerbbs.com/6c38bbee1121ea92508ad9508fa15c5e","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":2,"crmLevelSwitch":1},"htmlText":"More profits.","listText":"More profits.","text":"More profits.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/143518844","repostId":1141664359,"repostType":4,"repost":{"id":"1141664359","pubTimestamp":1625786702,"share":"https://www.laohu8.com/m/news/1141664359?lang=&edition=full","pubTime":"2021-07-09 07:25","market":"us","language":"en","title":"Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant","url":"https://stock-news.laohu8.com/highlight/detail?id=1141664359","media":"CNBC","summary":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot inten","content":"<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer says it is developing a Covid booster shot to target the highly transmissible delta variant\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-09 07:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1141664359","content_text":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to regulatory approvals.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated.\n\nPfizerandBioNTechannounced Thursday they are developing a Covid-19 booster shot intended to target the delta variant as concerns rise about the highly transmissible strain that is already the dominant form of the disease in the United States.\nThe companies said although they believe a third shot of their current two-dose vaccine has the potential to preserve the \"highest levels\" of protection against all currently known variants, including delta, they are \"remaining vigilant\" and developing an updated version of the vaccine.\n“As seen in real world evidence released from the Israel Ministry of Health, vaccine efficacy has declined six months post-vaccination, at the same time that the Delta variant is becoming the dominate variant in the country,” the companies said in a written statement.\n“These findings are consistent with an ongoing analysis from the companies’ Phase 3 study,” they said. “That is why we have said, and we continue to believe that it is likely, based on the totality of the data we have to date, that a third dose may be needed within 6 to 12 months after full vaccination.”\nClinical studies could begin as early as August, subject to regulatory approvals, the companies said.\nThe announcement comes the same day Olympics organizers saidthey are banning all spectatorsfrom the games this year after Japan declared a state of emergency that’s meant to curb a wave of new Covid-19 infections due in part to the delta variant.\nDelta is estimated by the World Health Organization to be about 55% more transmissible than alpha, the variant first found in the United Kingdom that once dominated the U.S. While current evidence shows Pfizer’s is highly effective against delta in preventing severe disease and death, it may not protect as well against mild disease and spreading the disease to others, scientists say.\nOn Monday, Israeli officialsreporteda decrease in the effectiveness of the Pfizer-BioNTech vaccine in preventing infections and symptomatic illness but said it remained highly effective in preventing serious illness.\nIn the U.S, health officials are urging all eligible Americans to get vaccinated as quickly as possible, especially before the fall season when delta isexpected to cause another surge in new coronavirus cases, particularly in places with the lowest vaccination rates.\nThere are about 1,000 counties in the U.S. that have Covid vaccination coverage of less than 30%, mostly located in the Southeast and Midwest, CDC Director Dr. Rochelle Walensky recently said. The agency is already seeing increasing rates of infection in those areas due to the further spread of the delta variant.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated because they expect vaccine-induced immunity to wane over time. They also said it’s likely people will need to get additional shots each year.\nPfizer and BioNTech are developing booster shots and are expected to shortly seek U.S. authorization for a third dose of its vaccine.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":143539949,"gmtCreate":1625800119981,"gmtModify":1703748827049,"author":{"id":"3581503320247876","authorId":"3581503320247876","name":"Grest","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Uptrend!","listText":"Uptrend!","text":"Uptrend!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/143539949","repostId":1141664359,"repostType":4,"repost":{"id":"1141664359","pubTimestamp":1625786702,"share":"https://www.laohu8.com/m/news/1141664359?lang=&edition=full","pubTime":"2021-07-09 07:25","market":"us","language":"en","title":"Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant","url":"https://stock-news.laohu8.com/highlight/detail?id=1141664359","media":"CNBC","summary":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot inten","content":"<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer says it is developing a Covid booster shot to target the highly transmissible delta variant\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-09 07:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1141664359","content_text":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to regulatory approvals.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated.\n\nPfizerandBioNTechannounced Thursday they are developing a Covid-19 booster shot intended to target the delta variant as concerns rise about the highly transmissible strain that is already the dominant form of the disease in the United States.\nThe companies said although they believe a third shot of their current two-dose vaccine has the potential to preserve the \"highest levels\" of protection against all currently known variants, including delta, they are \"remaining vigilant\" and developing an updated version of the vaccine.\n“As seen in real world evidence released from the Israel Ministry of Health, vaccine efficacy has declined six months post-vaccination, at the same time that the Delta variant is becoming the dominate variant in the country,” the companies said in a written statement.\n“These findings are consistent with an ongoing analysis from the companies’ Phase 3 study,” they said. “That is why we have said, and we continue to believe that it is likely, based on the totality of the data we have to date, that a third dose may be needed within 6 to 12 months after full vaccination.”\nClinical studies could begin as early as August, subject to regulatory approvals, the companies said.\nThe announcement comes the same day Olympics organizers saidthey are banning all spectatorsfrom the games this year after Japan declared a state of emergency that’s meant to curb a wave of new Covid-19 infections due in part to the delta variant.\nDelta is estimated by the World Health Organization to be about 55% more transmissible than alpha, the variant first found in the United Kingdom that once dominated the U.S. While current evidence shows Pfizer’s is highly effective against delta in preventing severe disease and death, it may not protect as well against mild disease and spreading the disease to others, scientists say.\nOn Monday, Israeli officialsreporteda decrease in the effectiveness of the Pfizer-BioNTech vaccine in preventing infections and symptomatic illness but said it remained highly effective in preventing serious illness.\nIn the U.S, health officials are urging all eligible Americans to get vaccinated as quickly as possible, especially before the fall season when delta isexpected to cause another surge in new coronavirus cases, particularly in places with the lowest vaccination rates.\nThere are about 1,000 counties in the U.S. that have Covid vaccination coverage of less than 30%, mostly located in the Southeast and Midwest, CDC Director Dr. Rochelle Walensky recently said. The agency is already seeing increasing rates of infection in those areas due to the further spread of the delta variant.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated because they expect vaccine-induced immunity to wane over time. They also said it’s likely people will need to get additional shots each year.\nPfizer and BioNTech are developing booster shots and are expected to shortly seek U.S. authorization for a third dose of its vaccine.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":143501199,"gmtCreate":1625798908911,"gmtModify":1703748799606,"author":{"id":"3574686466924712","authorId":"3574686466924712","name":"Ignis","avatar":"https://static.tigerbbs.com/543d1f3e8b4901fba226eb61e5713bc4","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":5,"crmLevelSwitch":0},"htmlText":"Better be better","listText":"Better be better","text":"Better be better","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/143501199","repostId":1141664359,"repostType":4,"repost":{"id":"1141664359","pubTimestamp":1625786702,"share":"https://www.laohu8.com/m/news/1141664359?lang=&edition=full","pubTime":"2021-07-09 07:25","market":"us","language":"en","title":"Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant","url":"https://stock-news.laohu8.com/highlight/detail?id=1141664359","media":"CNBC","summary":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot inten","content":"<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer says it is developing a Covid booster shot to target the highly transmissible delta variant\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-09 07:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1141664359","content_text":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to regulatory approvals.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated.\n\nPfizerandBioNTechannounced Thursday they are developing a Covid-19 booster shot intended to target the delta variant as concerns rise about the highly transmissible strain that is already the dominant form of the disease in the United States.\nThe companies said although they believe a third shot of their current two-dose vaccine has the potential to preserve the \"highest levels\" of protection against all currently known variants, including delta, they are \"remaining vigilant\" and developing an updated version of the vaccine.\n“As seen in real world evidence released from the Israel Ministry of Health, vaccine efficacy has declined six months post-vaccination, at the same time that the Delta variant is becoming the dominate variant in the country,” the companies said in a written statement.\n“These findings are consistent with an ongoing analysis from the companies’ Phase 3 study,” they said. “That is why we have said, and we continue to believe that it is likely, based on the totality of the data we have to date, that a third dose may be needed within 6 to 12 months after full vaccination.”\nClinical studies could begin as early as August, subject to regulatory approvals, the companies said.\nThe announcement comes the same day Olympics organizers saidthey are banning all spectatorsfrom the games this year after Japan declared a state of emergency that’s meant to curb a wave of new Covid-19 infections due in part to the delta variant.\nDelta is estimated by the World Health Organization to be about 55% more transmissible than alpha, the variant first found in the United Kingdom that once dominated the U.S. While current evidence shows Pfizer’s is highly effective against delta in preventing severe disease and death, it may not protect as well against mild disease and spreading the disease to others, scientists say.\nOn Monday, Israeli officialsreporteda decrease in the effectiveness of the Pfizer-BioNTech vaccine in preventing infections and symptomatic illness but said it remained highly effective in preventing serious illness.\nIn the U.S, health officials are urging all eligible Americans to get vaccinated as quickly as possible, especially before the fall season when delta isexpected to cause another surge in new coronavirus cases, particularly in places with the lowest vaccination rates.\nThere are about 1,000 counties in the U.S. that have Covid vaccination coverage of less than 30%, mostly located in the Southeast and Midwest, CDC Director Dr. Rochelle Walensky recently said. The agency is already seeing increasing rates of infection in those areas due to the further spread of the delta variant.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated because they expect vaccine-induced immunity to wane over time. They also said it’s likely people will need to get additional shots each year.\nPfizer and BioNTech are developing booster shots and are expected to shortly seek U.S. authorization for a third dose of its vaccine.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":143247102,"gmtCreate":1625798154006,"gmtModify":1703748778772,"author":{"id":"3586051882965466","authorId":"3586051882965466","name":"BurningSun","avatar":"https://static.tigerbbs.com/358b6a160727cb5e814434bf2f2265f9","vip":1,"hat":"https://static.tigerbbs.com/4c5ceab71416b120bab4604c0754b52a","crmLevel":3,"crmLevelSwitch":0},"htmlText":"From Alpha to Delta to ??? variant…. Can only hope for the best outcome for this pandamic","listText":"From Alpha to Delta to ??? variant…. Can only hope for the best outcome for this pandamic","text":"From Alpha to Delta to ??? variant…. Can only hope for the best outcome for this pandamic","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/143247102","repostId":1141664359,"repostType":4,"repost":{"id":"1141664359","pubTimestamp":1625786702,"share":"https://www.laohu8.com/m/news/1141664359?lang=&edition=full","pubTime":"2021-07-09 07:25","market":"us","language":"en","title":"Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant","url":"https://stock-news.laohu8.com/highlight/detail?id=1141664359","media":"CNBC","summary":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot inten","content":"<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer says it is developing a Covid booster shot to target the highly transmissible delta variant\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-09 07:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1141664359","content_text":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to regulatory approvals.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated.\n\nPfizerandBioNTechannounced Thursday they are developing a Covid-19 booster shot intended to target the delta variant as concerns rise about the highly transmissible strain that is already the dominant form of the disease in the United States.\nThe companies said although they believe a third shot of their current two-dose vaccine has the potential to preserve the \"highest levels\" of protection against all currently known variants, including delta, they are \"remaining vigilant\" and developing an updated version of the vaccine.\n“As seen in real world evidence released from the Israel Ministry of Health, vaccine efficacy has declined six months post-vaccination, at the same time that the Delta variant is becoming the dominate variant in the country,” the companies said in a written statement.\n“These findings are consistent with an ongoing analysis from the companies’ Phase 3 study,” they said. “That is why we have said, and we continue to believe that it is likely, based on the totality of the data we have to date, that a third dose may be needed within 6 to 12 months after full vaccination.”\nClinical studies could begin as early as August, subject to regulatory approvals, the companies said.\nThe announcement comes the same day Olympics organizers saidthey are banning all spectatorsfrom the games this year after Japan declared a state of emergency that’s meant to curb a wave of new Covid-19 infections due in part to the delta variant.\nDelta is estimated by the World Health Organization to be about 55% more transmissible than alpha, the variant first found in the United Kingdom that once dominated the U.S. While current evidence shows Pfizer’s is highly effective against delta in preventing severe disease and death, it may not protect as well against mild disease and spreading the disease to others, scientists say.\nOn Monday, Israeli officialsreporteda decrease in the effectiveness of the Pfizer-BioNTech vaccine in preventing infections and symptomatic illness but said it remained highly effective in preventing serious illness.\nIn the U.S, health officials are urging all eligible Americans to get vaccinated as quickly as possible, especially before the fall season when delta isexpected to cause another surge in new coronavirus cases, particularly in places with the lowest vaccination rates.\nThere are about 1,000 counties in the U.S. that have Covid vaccination coverage of less than 30%, mostly located in the Southeast and Midwest, CDC Director Dr. Rochelle Walensky recently said. The agency is already seeing increasing rates of infection in those areas due to the further spread of the delta variant.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated because they expect vaccine-induced immunity to wane over time. They also said it’s likely people will need to get additional shots each year.\nPfizer and BioNTech are developing booster shots and are expected to shortly seek U.S. authorization for a third dose of its vaccine.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":143268902,"gmtCreate":1625796417406,"gmtModify":1703748726582,"author":{"id":"3586941861951066","authorId":"3586941861951066","name":"EHG","avatar":"https://static.tigerbbs.com/28e4734e50f795c3218330cbb6c3e9a0","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/143268902","repostId":1141664359,"repostType":4,"repost":{"id":"1141664359","pubTimestamp":1625786702,"share":"https://www.laohu8.com/m/news/1141664359?lang=&edition=full","pubTime":"2021-07-09 07:25","market":"us","language":"en","title":"Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant","url":"https://stock-news.laohu8.com/highlight/detail?id=1141664359","media":"CNBC","summary":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot inten","content":"<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer says it is developing a Covid booster shot to target the highly transmissible delta variant\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-09 07:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1141664359","content_text":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to regulatory approvals.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated.\n\nPfizerandBioNTechannounced Thursday they are developing a Covid-19 booster shot intended to target the delta variant as concerns rise about the highly transmissible strain that is already the dominant form of the disease in the United States.\nThe companies said although they believe a third shot of their current two-dose vaccine has the potential to preserve the \"highest levels\" of protection against all currently known variants, including delta, they are \"remaining vigilant\" and developing an updated version of the vaccine.\n“As seen in real world evidence released from the Israel Ministry of Health, vaccine efficacy has declined six months post-vaccination, at the same time that the Delta variant is becoming the dominate variant in the country,” the companies said in a written statement.\n“These findings are consistent with an ongoing analysis from the companies’ Phase 3 study,” they said. “That is why we have said, and we continue to believe that it is likely, based on the totality of the data we have to date, that a third dose may be needed within 6 to 12 months after full vaccination.”\nClinical studies could begin as early as August, subject to regulatory approvals, the companies said.\nThe announcement comes the same day Olympics organizers saidthey are banning all spectatorsfrom the games this year after Japan declared a state of emergency that’s meant to curb a wave of new Covid-19 infections due in part to the delta variant.\nDelta is estimated by the World Health Organization to be about 55% more transmissible than alpha, the variant first found in the United Kingdom that once dominated the U.S. While current evidence shows Pfizer’s is highly effective against delta in preventing severe disease and death, it may not protect as well against mild disease and spreading the disease to others, scientists say.\nOn Monday, Israeli officialsreporteda decrease in the effectiveness of the Pfizer-BioNTech vaccine in preventing infections and symptomatic illness but said it remained highly effective in preventing serious illness.\nIn the U.S, health officials are urging all eligible Americans to get vaccinated as quickly as possible, especially before the fall season when delta isexpected to cause another surge in new coronavirus cases, particularly in places with the lowest vaccination rates.\nThere are about 1,000 counties in the U.S. that have Covid vaccination coverage of less than 30%, mostly located in the Southeast and Midwest, CDC Director Dr. Rochelle Walensky recently said. The agency is already seeing increasing rates of infection in those areas due to the further spread of the delta variant.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated because they expect vaccine-induced immunity to wane over time. They also said it’s likely people will need to get additional shots each year.\nPfizer and BioNTech are developing booster shots and are expected to shortly seek U.S. authorization for a third dose of its vaccine.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5168209,"gmtCreate":1625798902266,"gmtModify":1663230741645,"authorId":3574686466924712,"author":{"id":3574686466924712,"authorId":3574686466924712,"name":"Ignis","avatar":"https://static.tigerbbs.com/543d1f3e8b4901fba226eb61e5713bc4","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.02.01","exceedPercentage":"93.50%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":143268902,"type":1,"supId":0,"prevId":0,"content":"<u>hi</u>","text":"<u>hi</u>","html":"<u>hi</u>"}],"langContent":"EN"},{"id":143287617,"gmtCreate":1625796217239,"gmtModify":1703748718854,"author":{"id":"3568940418649845","authorId":"3568940418649845","name":"Chrnox","avatar":"https://static.tigerbbs.com/d8298e6f2695e61a0ffe90273947e675","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Like pls. Thank you","listText":"Like pls. Thank you","text":"Like pls. Thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/143287617","repostId":1141664359,"repostType":4,"repost":{"id":"1141664359","pubTimestamp":1625786702,"share":"https://www.laohu8.com/m/news/1141664359?lang=&edition=full","pubTime":"2021-07-09 07:25","market":"us","language":"en","title":"Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant","url":"https://stock-news.laohu8.com/highlight/detail?id=1141664359","media":"CNBC","summary":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot inten","content":"<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer says it is developing a Covid booster shot to target the highly transmissible delta variant\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-09 07:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1141664359","content_text":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to regulatory approvals.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated.\n\nPfizerandBioNTechannounced Thursday they are developing a Covid-19 booster shot intended to target the delta variant as concerns rise about the highly transmissible strain that is already the dominant form of the disease in the United States.\nThe companies said although they believe a third shot of their current two-dose vaccine has the potential to preserve the \"highest levels\" of protection against all currently known variants, including delta, they are \"remaining vigilant\" and developing an updated version of the vaccine.\n“As seen in real world evidence released from the Israel Ministry of Health, vaccine efficacy has declined six months post-vaccination, at the same time that the Delta variant is becoming the dominate variant in the country,” the companies said in a written statement.\n“These findings are consistent with an ongoing analysis from the companies’ Phase 3 study,” they said. “That is why we have said, and we continue to believe that it is likely, based on the totality of the data we have to date, that a third dose may be needed within 6 to 12 months after full vaccination.”\nClinical studies could begin as early as August, subject to regulatory approvals, the companies said.\nThe announcement comes the same day Olympics organizers saidthey are banning all spectatorsfrom the games this year after Japan declared a state of emergency that’s meant to curb a wave of new Covid-19 infections due in part to the delta variant.\nDelta is estimated by the World Health Organization to be about 55% more transmissible than alpha, the variant first found in the United Kingdom that once dominated the U.S. While current evidence shows Pfizer’s is highly effective against delta in preventing severe disease and death, it may not protect as well against mild disease and spreading the disease to others, scientists say.\nOn Monday, Israeli officialsreporteda decrease in the effectiveness of the Pfizer-BioNTech vaccine in preventing infections and symptomatic illness but said it remained highly effective in preventing serious illness.\nIn the U.S, health officials are urging all eligible Americans to get vaccinated as quickly as possible, especially before the fall season when delta isexpected to cause another surge in new coronavirus cases, particularly in places with the lowest vaccination rates.\nThere are about 1,000 counties in the U.S. that have Covid vaccination coverage of less than 30%, mostly located in the Southeast and Midwest, CDC Director Dr. Rochelle Walensky recently said. The agency is already seeing increasing rates of infection in those areas due to the further spread of the delta variant.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated because they expect vaccine-induced immunity to wane over time. They also said it’s likely people will need to get additional shots each year.\nPfizer and BioNTech are developing booster shots and are expected to shortly seek U.S. authorization for a third dose of its vaccine.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":143281873,"gmtCreate":1625796037692,"gmtModify":1703748711343,"author":{"id":"3577494565516476","authorId":"3577494565516476","name":"fidllama","avatar":"https://community-static.tradeup.com/news/df43ce0653d590390fc3431ea46d58ef","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"okay wow","listText":"okay wow","text":"okay wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/143281873","repostId":1141664359,"repostType":4,"repost":{"id":"1141664359","pubTimestamp":1625786702,"share":"https://www.laohu8.com/m/news/1141664359?lang=&edition=full","pubTime":"2021-07-09 07:25","market":"us","language":"en","title":"Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant","url":"https://stock-news.laohu8.com/highlight/detail?id=1141664359","media":"CNBC","summary":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot inten","content":"<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer says it is developing a Covid booster shot to target the highly transmissible delta variant\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-09 07:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1141664359","content_text":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to regulatory approvals.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated.\n\nPfizerandBioNTechannounced Thursday they are developing a Covid-19 booster shot intended to target the delta variant as concerns rise about the highly transmissible strain that is already the dominant form of the disease in the United States.\nThe companies said although they believe a third shot of their current two-dose vaccine has the potential to preserve the \"highest levels\" of protection against all currently known variants, including delta, they are \"remaining vigilant\" and developing an updated version of the vaccine.\n“As seen in real world evidence released from the Israel Ministry of Health, vaccine efficacy has declined six months post-vaccination, at the same time that the Delta variant is becoming the dominate variant in the country,” the companies said in a written statement.\n“These findings are consistent with an ongoing analysis from the companies’ Phase 3 study,” they said. “That is why we have said, and we continue to believe that it is likely, based on the totality of the data we have to date, that a third dose may be needed within 6 to 12 months after full vaccination.”\nClinical studies could begin as early as August, subject to regulatory approvals, the companies said.\nThe announcement comes the same day Olympics organizers saidthey are banning all spectatorsfrom the games this year after Japan declared a state of emergency that’s meant to curb a wave of new Covid-19 infections due in part to the delta variant.\nDelta is estimated by the World Health Organization to be about 55% more transmissible than alpha, the variant first found in the United Kingdom that once dominated the U.S. While current evidence shows Pfizer’s is highly effective against delta in preventing severe disease and death, it may not protect as well against mild disease and spreading the disease to others, scientists say.\nOn Monday, Israeli officialsreporteda decrease in the effectiveness of the Pfizer-BioNTech vaccine in preventing infections and symptomatic illness but said it remained highly effective in preventing serious illness.\nIn the U.S, health officials are urging all eligible Americans to get vaccinated as quickly as possible, especially before the fall season when delta isexpected to cause another surge in new coronavirus cases, particularly in places with the lowest vaccination rates.\nThere are about 1,000 counties in the U.S. that have Covid vaccination coverage of less than 30%, mostly located in the Southeast and Midwest, CDC Director Dr. Rochelle Walensky recently said. The agency is already seeing increasing rates of infection in those areas due to the further spread of the delta variant.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated because they expect vaccine-induced immunity to wane over time. They also said it’s likely people will need to get additional shots each year.\nPfizer and BioNTech are developing booster shots and are expected to shortly seek U.S. authorization for a third dose of its vaccine.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":143232868,"gmtCreate":1625795419254,"gmtModify":1703748685487,"author":{"id":"3580699589385230","authorId":"3580699589385230","name":"Mr. T","avatar":"https://static.tigerbbs.com/ffcbb09604bf679c78d4b172e4ad0c39","vip":1,"hat":"https://static.tigerbbs.com/4c5ceab71416b120bab4604c0754b52a","crmLevel":3,"crmLevelSwitch":0},"htmlText":"Please like","listText":"Please like","text":"Please like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/143232868","repostId":1141664359,"repostType":4,"repost":{"id":"1141664359","pubTimestamp":1625786702,"share":"https://www.laohu8.com/m/news/1141664359?lang=&edition=full","pubTime":"2021-07-09 07:25","market":"us","language":"en","title":"Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant","url":"https://stock-news.laohu8.com/highlight/detail?id=1141664359","media":"CNBC","summary":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot inten","content":"<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer says it is developing a Covid booster shot to target the highly transmissible delta variant\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-09 07:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1141664359","content_text":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to regulatory approvals.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated.\n\nPfizerandBioNTechannounced Thursday they are developing a Covid-19 booster shot intended to target the delta variant as concerns rise about the highly transmissible strain that is already the dominant form of the disease in the United States.\nThe companies said although they believe a third shot of their current two-dose vaccine has the potential to preserve the \"highest levels\" of protection against all currently known variants, including delta, they are \"remaining vigilant\" and developing an updated version of the vaccine.\n“As seen in real world evidence released from the Israel Ministry of Health, vaccine efficacy has declined six months post-vaccination, at the same time that the Delta variant is becoming the dominate variant in the country,” the companies said in a written statement.\n“These findings are consistent with an ongoing analysis from the companies’ Phase 3 study,” they said. “That is why we have said, and we continue to believe that it is likely, based on the totality of the data we have to date, that a third dose may be needed within 6 to 12 months after full vaccination.”\nClinical studies could begin as early as August, subject to regulatory approvals, the companies said.\nThe announcement comes the same day Olympics organizers saidthey are banning all spectatorsfrom the games this year after Japan declared a state of emergency that’s meant to curb a wave of new Covid-19 infections due in part to the delta variant.\nDelta is estimated by the World Health Organization to be about 55% more transmissible than alpha, the variant first found in the United Kingdom that once dominated the U.S. While current evidence shows Pfizer’s is highly effective against delta in preventing severe disease and death, it may not protect as well against mild disease and spreading the disease to others, scientists say.\nOn Monday, Israeli officialsreporteda decrease in the effectiveness of the Pfizer-BioNTech vaccine in preventing infections and symptomatic illness but said it remained highly effective in preventing serious illness.\nIn the U.S, health officials are urging all eligible Americans to get vaccinated as quickly as possible, especially before the fall season when delta isexpected to cause another surge in new coronavirus cases, particularly in places with the lowest vaccination rates.\nThere are about 1,000 counties in the U.S. that have Covid vaccination coverage of less than 30%, mostly located in the Southeast and Midwest, CDC Director Dr. Rochelle Walensky recently said. The agency is already seeing increasing rates of infection in those areas due to the further spread of the delta variant.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated because they expect vaccine-induced immunity to wane over time. They also said it’s likely people will need to get additional shots each year.\nPfizer and BioNTech are developing booster shots and are expected to shortly seek U.S. authorization for a third dose of its vaccine.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":143230990,"gmtCreate":1625795171910,"gmtModify":1703748675886,"author":{"id":"3583210195403389","authorId":"3583210195403389","name":"Yuanecute","avatar":"https://static.tigerbbs.com/b16771be0bfff1b89dc4e942803ce2c2","vip":1,"crmLevel":2,"crmLevelSwitch":1},"htmlText":"pls like n comment","listText":"pls like n comment","text":"pls like n comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/143230990","repostId":1141664359,"repostType":4,"repost":{"id":"1141664359","pubTimestamp":1625786702,"share":"https://www.laohu8.com/m/news/1141664359?lang=&edition=full","pubTime":"2021-07-09 07:25","market":"us","language":"en","title":"Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant","url":"https://stock-news.laohu8.com/highlight/detail?id=1141664359","media":"CNBC","summary":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot inten","content":"<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer says it is developing a Covid booster shot to target the highly transmissible delta variant\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-09 07:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1141664359","content_text":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to regulatory approvals.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated.\n\nPfizerandBioNTechannounced Thursday they are developing a Covid-19 booster shot intended to target the delta variant as concerns rise about the highly transmissible strain that is already the dominant form of the disease in the United States.\nThe companies said although they believe a third shot of their current two-dose vaccine has the potential to preserve the \"highest levels\" of protection against all currently known variants, including delta, they are \"remaining vigilant\" and developing an updated version of the vaccine.\n“As seen in real world evidence released from the Israel Ministry of Health, vaccine efficacy has declined six months post-vaccination, at the same time that the Delta variant is becoming the dominate variant in the country,” the companies said in a written statement.\n“These findings are consistent with an ongoing analysis from the companies’ Phase 3 study,” they said. “That is why we have said, and we continue to believe that it is likely, based on the totality of the data we have to date, that a third dose may be needed within 6 to 12 months after full vaccination.”\nClinical studies could begin as early as August, subject to regulatory approvals, the companies said.\nThe announcement comes the same day Olympics organizers saidthey are banning all spectatorsfrom the games this year after Japan declared a state of emergency that’s meant to curb a wave of new Covid-19 infections due in part to the delta variant.\nDelta is estimated by the World Health Organization to be about 55% more transmissible than alpha, the variant first found in the United Kingdom that once dominated the U.S. While current evidence shows Pfizer’s is highly effective against delta in preventing severe disease and death, it may not protect as well against mild disease and spreading the disease to others, scientists say.\nOn Monday, Israeli officialsreporteda decrease in the effectiveness of the Pfizer-BioNTech vaccine in preventing infections and symptomatic illness but said it remained highly effective in preventing serious illness.\nIn the U.S, health officials are urging all eligible Americans to get vaccinated as quickly as possible, especially before the fall season when delta isexpected to cause another surge in new coronavirus cases, particularly in places with the lowest vaccination rates.\nThere are about 1,000 counties in the U.S. that have Covid vaccination coverage of less than 30%, mostly located in the Southeast and Midwest, CDC Director Dr. Rochelle Walensky recently said. The agency is already seeing increasing rates of infection in those areas due to the further spread of the delta variant.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated because they expect vaccine-induced immunity to wane over time. They also said it’s likely people will need to get additional shots each year.\nPfizer and BioNTech are developing booster shots and are expected to shortly seek U.S. authorization for a third dose of its vaccine.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5191884,"gmtCreate":1626053561764,"gmtModify":1663230847242,"authorId":3583210195403389,"author":{"id":3583210195403389,"authorId":3583210195403389,"name":"Yuanecute","avatar":"https://static.tigerbbs.com/b16771be0bfff1b89dc4e942803ce2c2","vip":1,"crmLevel":2,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":143230990,"type":1,"supId":5168871,"prevId":0,"content":"thanks","text":"thanks","html":"thanks"},{"id":5178844,"gmtCreate":1625885006944,"gmtModify":1663230785525,"authorId":3583210195403389,"author":{"id":3583210195403389,"authorId":3583210195403389,"name":"Yuanecute","avatar":"https://static.tigerbbs.com/b16771be0bfff1b89dc4e942803ce2c2","vip":1,"crmLevel":2,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":143230990,"type":1,"supId":5168871,"prevId":0,"content":"thanks","text":"thanks","html":"thanks"},{"id":5168871,"gmtCreate":1625802819287,"gmtModify":1663230744247,"authorId":3572988793196593,"author":{"id":3572988793196593,"authorId":3572988793196593,"name":"Foxie","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":143230990,"type":1,"supId":0,"prevId":0,"content":"Good","text":"Good","html":"Good"},{"id":5167548,"gmtCreate":1625795412375,"gmtModify":1663230739245,"authorId":3580699589385230,"author":{"id":3580699589385230,"authorId":3580699589385230,"name":"Mr. T","avatar":"https://static.tigerbbs.com/ffcbb09604bf679c78d4b172e4ad0c39","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.20%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":143230990,"type":1,"supId":0,"prevId":0,"content":"Done","text":"Done","html":"Done"}],"langContent":"EN"},{"id":143293925,"gmtCreate":1625794836667,"gmtModify":1703748665724,"author":{"id":"3585131446723491","authorId":"3585131446723491","name":"Sharon87","avatar":"https://static.tigerbbs.com/85393cfd80f8cbaf580d4968e8a0640a","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Thats good to hear!","listText":"Thats good to hear!","text":"Thats good to hear!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/143293925","repostId":1141664359,"repostType":4,"repost":{"id":"1141664359","pubTimestamp":1625786702,"share":"https://www.laohu8.com/m/news/1141664359?lang=&edition=full","pubTime":"2021-07-09 07:25","market":"us","language":"en","title":"Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant","url":"https://stock-news.laohu8.com/highlight/detail?id=1141664359","media":"CNBC","summary":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot inten","content":"<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer says it is developing a Covid booster shot to target the highly transmissible delta variant\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-09 07:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1141664359","content_text":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to regulatory approvals.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated.\n\nPfizerandBioNTechannounced Thursday they are developing a Covid-19 booster shot intended to target the delta variant as concerns rise about the highly transmissible strain that is already the dominant form of the disease in the United States.\nThe companies said although they believe a third shot of their current two-dose vaccine has the potential to preserve the \"highest levels\" of protection against all currently known variants, including delta, they are \"remaining vigilant\" and developing an updated version of the vaccine.\n“As seen in real world evidence released from the Israel Ministry of Health, vaccine efficacy has declined six months post-vaccination, at the same time that the Delta variant is becoming the dominate variant in the country,” the companies said in a written statement.\n“These findings are consistent with an ongoing analysis from the companies’ Phase 3 study,” they said. “That is why we have said, and we continue to believe that it is likely, based on the totality of the data we have to date, that a third dose may be needed within 6 to 12 months after full vaccination.”\nClinical studies could begin as early as August, subject to regulatory approvals, the companies said.\nThe announcement comes the same day Olympics organizers saidthey are banning all spectatorsfrom the games this year after Japan declared a state of emergency that’s meant to curb a wave of new Covid-19 infections due in part to the delta variant.\nDelta is estimated by the World Health Organization to be about 55% more transmissible than alpha, the variant first found in the United Kingdom that once dominated the U.S. While current evidence shows Pfizer’s is highly effective against delta in preventing severe disease and death, it may not protect as well against mild disease and spreading the disease to others, scientists say.\nOn Monday, Israeli officialsreporteda decrease in the effectiveness of the Pfizer-BioNTech vaccine in preventing infections and symptomatic illness but said it remained highly effective in preventing serious illness.\nIn the U.S, health officials are urging all eligible Americans to get vaccinated as quickly as possible, especially before the fall season when delta isexpected to cause another surge in new coronavirus cases, particularly in places with the lowest vaccination rates.\nThere are about 1,000 counties in the U.S. that have Covid vaccination coverage of less than 30%, mostly located in the Southeast and Midwest, CDC Director Dr. Rochelle Walensky recently said. The agency is already seeing increasing rates of infection in those areas due to the further spread of the delta variant.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated because they expect vaccine-induced immunity to wane over time. They also said it’s likely people will need to get additional shots each year.\nPfizer and BioNTech are developing booster shots and are expected to shortly seek U.S. authorization for a third dose of its vaccine.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":143290847,"gmtCreate":1625794783589,"gmtModify":1703748663440,"author":{"id":"3574766349354741","authorId":"3574766349354741","name":"TK360","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0},"htmlText":"Great&nbsp;","listText":"Great&nbsp;","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/143290847","repostId":1141664359,"repostType":4,"repost":{"id":"1141664359","pubTimestamp":1625786702,"share":"https://www.laohu8.com/m/news/1141664359?lang=&edition=full","pubTime":"2021-07-09 07:25","market":"us","language":"en","title":"Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant","url":"https://stock-news.laohu8.com/highlight/detail?id=1141664359","media":"CNBC","summary":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot inten","content":"<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer says it is developing a Covid booster shot to target the highly transmissible delta variant\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-09 07:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1141664359","content_text":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to regulatory approvals.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated.\n\nPfizerandBioNTechannounced Thursday they are developing a Covid-19 booster shot intended to target the delta variant as concerns rise about the highly transmissible strain that is already the dominant form of the disease in the United States.\nThe companies said although they believe a third shot of their current two-dose vaccine has the potential to preserve the \"highest levels\" of protection against all currently known variants, including delta, they are \"remaining vigilant\" and developing an updated version of the vaccine.\n“As seen in real world evidence released from the Israel Ministry of Health, vaccine efficacy has declined six months post-vaccination, at the same time that the Delta variant is becoming the dominate variant in the country,” the companies said in a written statement.\n“These findings are consistent with an ongoing analysis from the companies’ Phase 3 study,” they said. “That is why we have said, and we continue to believe that it is likely, based on the totality of the data we have to date, that a third dose may be needed within 6 to 12 months after full vaccination.”\nClinical studies could begin as early as August, subject to regulatory approvals, the companies said.\nThe announcement comes the same day Olympics organizers saidthey are banning all spectatorsfrom the games this year after Japan declared a state of emergency that’s meant to curb a wave of new Covid-19 infections due in part to the delta variant.\nDelta is estimated by the World Health Organization to be about 55% more transmissible than alpha, the variant first found in the United Kingdom that once dominated the U.S. While current evidence shows Pfizer’s is highly effective against delta in preventing severe disease and death, it may not protect as well against mild disease and spreading the disease to others, scientists say.\nOn Monday, Israeli officialsreporteda decrease in the effectiveness of the Pfizer-BioNTech vaccine in preventing infections and symptomatic illness but said it remained highly effective in preventing serious illness.\nIn the U.S, health officials are urging all eligible Americans to get vaccinated as quickly as possible, especially before the fall season when delta isexpected to cause another surge in new coronavirus cases, particularly in places with the lowest vaccination rates.\nThere are about 1,000 counties in the U.S. that have Covid vaccination coverage of less than 30%, mostly located in the Southeast and Midwest, CDC Director Dr. Rochelle Walensky recently said. The agency is already seeing increasing rates of infection in those areas due to the further spread of the delta variant.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated because they expect vaccine-induced immunity to wane over time. They also said it’s likely people will need to get additional shots each year.\nPfizer and BioNTech are developing booster shots and are expected to shortly seek U.S. authorization for a third dose of its vaccine.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":143206974,"gmtCreate":1625794537798,"gmtModify":1703748655161,"author":{"id":"3584182854667058","authorId":"3584182854667058","name":"BeautyTrade","avatar":"https://static.tigerbbs.com/63f8e238d1760fe32b24660344219105","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Non stop vaccine","listText":"Non stop vaccine","text":"Non stop vaccine","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/143206974","repostId":1141664359,"repostType":4,"repost":{"id":"1141664359","pubTimestamp":1625786702,"share":"https://www.laohu8.com/m/news/1141664359?lang=&edition=full","pubTime":"2021-07-09 07:25","market":"us","language":"en","title":"Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant","url":"https://stock-news.laohu8.com/highlight/detail?id=1141664359","media":"CNBC","summary":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot inten","content":"<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer says it is developing a Covid booster shot to target the highly transmissible delta variant\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-09 07:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1141664359","content_text":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to regulatory approvals.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated.\n\nPfizerandBioNTechannounced Thursday they are developing a Covid-19 booster shot intended to target the delta variant as concerns rise about the highly transmissible strain that is already the dominant form of the disease in the United States.\nThe companies said although they believe a third shot of their current two-dose vaccine has the potential to preserve the \"highest levels\" of protection against all currently known variants, including delta, they are \"remaining vigilant\" and developing an updated version of the vaccine.\n“As seen in real world evidence released from the Israel Ministry of Health, vaccine efficacy has declined six months post-vaccination, at the same time that the Delta variant is becoming the dominate variant in the country,” the companies said in a written statement.\n“These findings are consistent with an ongoing analysis from the companies’ Phase 3 study,” they said. “That is why we have said, and we continue to believe that it is likely, based on the totality of the data we have to date, that a third dose may be needed within 6 to 12 months after full vaccination.”\nClinical studies could begin as early as August, subject to regulatory approvals, the companies said.\nThe announcement comes the same day Olympics organizers saidthey are banning all spectatorsfrom the games this year after Japan declared a state of emergency that’s meant to curb a wave of new Covid-19 infections due in part to the delta variant.\nDelta is estimated by the World Health Organization to be about 55% more transmissible than alpha, the variant first found in the United Kingdom that once dominated the U.S. While current evidence shows Pfizer’s is highly effective against delta in preventing severe disease and death, it may not protect as well against mild disease and spreading the disease to others, scientists say.\nOn Monday, Israeli officialsreporteda decrease in the effectiveness of the Pfizer-BioNTech vaccine in preventing infections and symptomatic illness but said it remained highly effective in preventing serious illness.\nIn the U.S, health officials are urging all eligible Americans to get vaccinated as quickly as possible, especially before the fall season when delta isexpected to cause another surge in new coronavirus cases, particularly in places with the lowest vaccination rates.\nThere are about 1,000 counties in the U.S. that have Covid vaccination coverage of less than 30%, mostly located in the Southeast and Midwest, CDC Director Dr. Rochelle Walensky recently said. The agency is already seeing increasing rates of infection in those areas due to the further spread of the delta variant.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated because they expect vaccine-induced immunity to wane over time. They also said it’s likely people will need to get additional shots each year.\nPfizer and BioNTech are developing booster shots and are expected to shortly seek U.S. authorization for a third dose of its vaccine.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5167437,"gmtCreate":1625794865622,"gmtModify":1663230740049,"authorId":3572154407630993,"author":{"id":3572154407630993,"authorId":3572154407630993,"name":"Julisuqin","avatar":"https://static.tigerbbs.com/b34ce74ed3696920f4bd3d4a0c9f046b","vip":1,"crmLevel":4,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":143206974,"type":1,"supId":0,"prevId":0,"content":"Indeed, need to be mentally prepared every year now","text":"Indeed, need to be mentally prepared every year now","html":"Indeed, need to be mentally prepared every year now"}],"langContent":"EN"},{"id":143673334,"gmtCreate":1625793958128,"gmtModify":1703748635452,"author":{"id":"3578903100181699","authorId":"3578903100181699","name":"Lamborghini1","avatar":"https://static.tigerbbs.com/f8b24a649554234324e1e33be42fc25f","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"Yes","listText":"Yes","text":"Yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/143673334","repostId":1141664359,"repostType":4,"repost":{"id":"1141664359","pubTimestamp":1625786702,"share":"https://www.laohu8.com/m/news/1141664359?lang=&edition=full","pubTime":"2021-07-09 07:25","market":"us","language":"en","title":"Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant","url":"https://stock-news.laohu8.com/highlight/detail?id=1141664359","media":"CNBC","summary":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot inten","content":"<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer says it is developing a Covid booster shot to target the highly transmissible delta variant\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-09 07:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1141664359","content_text":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to regulatory approvals.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated.\n\nPfizerandBioNTechannounced Thursday they are developing a Covid-19 booster shot intended to target the delta variant as concerns rise about the highly transmissible strain that is already the dominant form of the disease in the United States.\nThe companies said although they believe a third shot of their current two-dose vaccine has the potential to preserve the \"highest levels\" of protection against all currently known variants, including delta, they are \"remaining vigilant\" and developing an updated version of the vaccine.\n“As seen in real world evidence released from the Israel Ministry of Health, vaccine efficacy has declined six months post-vaccination, at the same time that the Delta variant is becoming the dominate variant in the country,” the companies said in a written statement.\n“These findings are consistent with an ongoing analysis from the companies’ Phase 3 study,” they said. “That is why we have said, and we continue to believe that it is likely, based on the totality of the data we have to date, that a third dose may be needed within 6 to 12 months after full vaccination.”\nClinical studies could begin as early as August, subject to regulatory approvals, the companies said.\nThe announcement comes the same day Olympics organizers saidthey are banning all spectatorsfrom the games this year after Japan declared a state of emergency that’s meant to curb a wave of new Covid-19 infections due in part to the delta variant.\nDelta is estimated by the World Health Organization to be about 55% more transmissible than alpha, the variant first found in the United Kingdom that once dominated the U.S. While current evidence shows Pfizer’s is highly effective against delta in preventing severe disease and death, it may not protect as well against mild disease and spreading the disease to others, scientists say.\nOn Monday, Israeli officialsreporteda decrease in the effectiveness of the Pfizer-BioNTech vaccine in preventing infections and symptomatic illness but said it remained highly effective in preventing serious illness.\nIn the U.S, health officials are urging all eligible Americans to get vaccinated as quickly as possible, especially before the fall season when delta isexpected to cause another surge in new coronavirus cases, particularly in places with the lowest vaccination rates.\nThere are about 1,000 counties in the U.S. that have Covid vaccination coverage of less than 30%, mostly located in the Southeast and Midwest, CDC Director Dr. Rochelle Walensky recently said. The agency is already seeing increasing rates of infection in those areas due to the further spread of the delta variant.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated because they expect vaccine-induced immunity to wane over time. They also said it’s likely people will need to get additional shots each year.\nPfizer and BioNTech are developing booster shots and are expected to shortly seek U.S. authorization for a third dose of its vaccine.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":143653898,"gmtCreate":1625793003414,"gmtModify":1703748607191,"author":{"id":"3569195494828163","authorId":"3569195494828163","name":"cyak","avatar":"https://static.tigerbbs.com/718beb287a4991c45488d225efae05a2","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"That fast?","listText":"That fast?","text":"That fast?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/143653898","repostId":1141664359,"repostType":4,"repost":{"id":"1141664359","pubTimestamp":1625786702,"share":"https://www.laohu8.com/m/news/1141664359?lang=&edition=full","pubTime":"2021-07-09 07:25","market":"us","language":"en","title":"Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant","url":"https://stock-news.laohu8.com/highlight/detail?id=1141664359","media":"CNBC","summary":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot inten","content":"<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer says it is developing a Covid booster shot to target the highly transmissible delta variant\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-09 07:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.cnbc.com/2021/07/08/pfizer-says-it-is-developing-a-covid-booster-shot-to-target-the-highly-transmissible-delta-variant.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1141664359","content_text":"KEY POINTS\n\nPfizer and BioNTech announced Thursday they are developing a Covid-19 booster shot intended to target the delta variant.\nClinical studies could begin as early as August, subject to regulatory approvals.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated.\n\nPfizerandBioNTechannounced Thursday they are developing a Covid-19 booster shot intended to target the delta variant as concerns rise about the highly transmissible strain that is already the dominant form of the disease in the United States.\nThe companies said although they believe a third shot of their current two-dose vaccine has the potential to preserve the \"highest levels\" of protection against all currently known variants, including delta, they are \"remaining vigilant\" and developing an updated version of the vaccine.\n“As seen in real world evidence released from the Israel Ministry of Health, vaccine efficacy has declined six months post-vaccination, at the same time that the Delta variant is becoming the dominate variant in the country,” the companies said in a written statement.\n“These findings are consistent with an ongoing analysis from the companies’ Phase 3 study,” they said. “That is why we have said, and we continue to believe that it is likely, based on the totality of the data we have to date, that a third dose may be needed within 6 to 12 months after full vaccination.”\nClinical studies could begin as early as August, subject to regulatory approvals, the companies said.\nThe announcement comes the same day Olympics organizers saidthey are banning all spectatorsfrom the games this year after Japan declared a state of emergency that’s meant to curb a wave of new Covid-19 infections due in part to the delta variant.\nDelta is estimated by the World Health Organization to be about 55% more transmissible than alpha, the variant first found in the United Kingdom that once dominated the U.S. While current evidence shows Pfizer’s is highly effective against delta in preventing severe disease and death, it may not protect as well against mild disease and spreading the disease to others, scientists say.\nOn Monday, Israeli officialsreporteda decrease in the effectiveness of the Pfizer-BioNTech vaccine in preventing infections and symptomatic illness but said it remained highly effective in preventing serious illness.\nIn the U.S, health officials are urging all eligible Americans to get vaccinated as quickly as possible, especially before the fall season when delta isexpected to cause another surge in new coronavirus cases, particularly in places with the lowest vaccination rates.\nThere are about 1,000 counties in the U.S. that have Covid vaccination coverage of less than 30%, mostly located in the Southeast and Midwest, CDC Director Dr. Rochelle Walensky recently said. The agency is already seeing increasing rates of infection in those areas due to the further spread of the delta variant.\nExecutives from Pfizer and BioNtech have repeatedly said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated because they expect vaccine-induced immunity to wane over time. They also said it’s likely people will need to get additional shots each year.\nPfizer and BioNTech are developing booster shots and are expected to shortly seek U.S. authorization for a third dose of its vaccine.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":190,"commentSize":41,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}